Tumor Necrosis Factor Soluble Receptor I (TNF sRI) from mouse, , >97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell culture tested

Code: t3564-50ug D2-231

Not available outside of the UK & Ireland.

Analysis Note

The biological activity is measured by its ability to inhibit the recombinant mouse TNF-α mediated cytotoxicity in mouse L929 cells, in the presence of the meta...


read more

Your Price
$836.00 50UG

Not available outside of the UK & Ireland.

Analysis Note

The biological activity is measured by its ability to inhibit the recombinant mouse TNF-α mediated cytotoxicity in mouse L929 cells, in the presence of the metabolic inhibitor actinomycin D.

Application

Tumor Necrosis Factor Soluble Receptor I (TNF sRI) from mouse plays a pivotal role in the signaling of apoptosis and NF-κB activation because of its “death domain” present at the intracellular portion.

Biochem/physiol Actions

Tumor Necrosis Factor Soluble Receptor I (TNF sRI) from mouse belongs to TNF family of receptors and has a pivotal role in neutralizing the biological activities of both TNF-α and TNF-β. Soluble tumor necrosis factor receptor along with intrathecal interleukin-1 receptor antagonist shows an anti-allodynic action in rat L5 spinal nerve transection model of neuropathic pain.

Physical form

Lyophilized from a 0.2 µm filtered solution in phosphate buffered saline with 2.5 mg bovine serum albumin

assay>97% (SDS-PAGE)
biological sourcemouse
formlyophilized powder
Gene Informationmouse ... Tnfrsf1a(21937)
impuritiesendotoxin, tested
mol wt21 kDa
packagingpkg of 50 µg
potency0.5-1.5 µg/mL ED50
Quality Level200
recombinantexpressed in E. coli
storage conditionavoid repeated freeze/thaw cycles
storage temp.−20°C
technique(s)cell culture | mammalian: suitable
UniProt accession no.P06804
This product has met the following criteria: